NYSEMKT: IBOImpact Biomedical Inc Stock Ownership - Who owns Impact Biomedical?
Insider buying vs selling
Have Impact Biomedical Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Todd D. MacKo | Chief Financial Officer | 2026-03-27 | 43,400 | $0.56 | $24.35kSell |
| Todd D. MacKo | Chief Financial Officer | 2026-03-25 | 1,600 | $0.60 | $961.60Sell |
| Jason Grady | Director | 2026-03-23 | 50,000 | $0.65 | $32.50kSell |
IBO insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when IBO insiders and whales buy or sell their stock.
IBO Shareholders
What type of owners hold Impact Biomedical Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Dss Inc | 2.37% | 2,556,906 | $1.21M | Insider |
| Geode Capital Management LLC | 1.11% | 1,192,925 | $563.06k | Institution |
| Vanguard Capital Management LLC | 0.66% | 708,168 | $334.26k | Institution |
| State Street Corp | 0.56% | 607,897 | $286.93k | Institution |
| Vanguard Fiduciary Trust Co | 0.54% | 585,198 | $276.21k | Institution |
| Blackrock Inc | 0.24% | 259,946 | $122.69k | Institution |
| Jason Grady | 0.23% | 250,182 | $118.09k | Insider |
| Northern Trust Corp | 0.23% | 243,943 | $115.14k | Institution |
| Todd D. MacKo | 0.14% | 155,122 | $73.22k | Insider |
| Frank D. Heuszel | 0.09% | 97,344 | $45.95k | Insider |
IBO vs Biotech Stocks
Impact Biomedical Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.